- Date and Time: 9 a.m. March 30 (Wed), 2016

- Location: Lee Kun-hee Hall, Samsung Cancer Research Institute Level 2, 

Seoul National University Medical School

 

 

We inform you that this general meeting of shareholders was conducted under the requirements by which resolutions can be legally made according to article 368 and article 434 of the commercial law.

 

-Report and Resolution Details

A. Report Details

   1. Audit Report

2. Business Report

3. External Auditor Appointment Report

* Accounting Auditor’s Opinion: Reasonable

B. Miscellaneous Resolution Details

Item 1: Approval for the 15^th Financial Statements -> Approval granted as proposed

Item 2: Modification of the Articles of Association -> Approval granted as proposed

Item 3: Revision of Executive Severance Pay Provisions -> Approval granted as proposed

Item 4: Granting Stock Options -> Approval granted as proposed

Item 5: Appointing Directors

Item 5-1: Appointing Inside Directors Yun-sik Kang and Ja-won Kim -> Approval granted as proposed

Item 5: Appointing Outside Directors Yeon-ju Cho and Seung-woon Eun -> Approval granted as proposed

Item 6: Appointing Auditors  Approval granted as proposed

Item 7: Approval for Director Compensation Limits -> Approval granted as proposed

Item 8: Approval for Auditor Compensation Limits -> Approval granted as proposed

 

Thank You

 

BIOINFRA Inc.